Intravitreal pegabtanib sodium in choroidal neovascularization secondary to angioid streaks.
Molina Guilabert
Ines
I
Calvo-González
Cristina
C
Reche-Frutos
Juan
J
Donate-López
Juan
J
García-Feijoó
Julián
J
Leila
M
M
García-Sánchez
Julián
J
D000328:Adult; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000793:Angioid Streaks / Q000150:complications*; D052157:Aptamers, Nucleotide / Q000008:administration & dosage*; D020256:Choroidal Neovascularization / Q000188:drug therapy* / Q000209:etiology*; D004487:Edema / Q000150:complications / Q000175:diagnosis; D005451:Fluorescein Angiography; D006801:Humans; D007267:Injections; D008297:Male; D012163:Retinal Detachment / Q000150:complications / Q000175:diagnosis; D012164:Retinal Diseases / Q000150:complications / Q000175:diagnosis; D041623:Tomography, Optical Coherence; D014822:Vitreous Body
D020533:Angiogenesis Inhibitors; D052157:Aptamers, Nucleotide; C495058:pegaptanib